Search research articles
Contact Us
Filters
Showing results (201-210 of 301) with videos related to
Page
of 31
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 2, 2024
The Health Benefits, Costs, and Cost-Effectiveness of Ultraorphan Drugs
Katherine A Clifford, A Alex Levine, Daniel E Enright, et al.
JAMA
|
September 29, 2025
Variation in US Commercial Health Plan Coverage Restrictions for Cell and Gene Therapies
James D Chambers, Julia A Rucker, Daniel E Enright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2002
Impact of referral patterns on the use of chemotherapy for lung cancer
Craig C Earle, Peter J Neumann, Richard D Gelber, et al.
Journal of General Internal Medicine
|
April 16, 2020
Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan Drugs
James D Chambers, Madison C Silver, Flora C Berklein, et al.
Journal of Managed Care Pharmacy : JMCP
|
May 4, 2010
Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus
Joseph Menzin, Jonathan R Korn, Joseph Cohen, et al.
Health Economics
|
May 6, 2004
When does quality-adjusting life-years matter in cost-effectiveness analysis?
Richard H Chapman, Marc Berger, Milton C Weinstein, et al.
Medical Care
|
August 29, 2022
Effect of the 2012 US Preventive Services Task Force Recommendations on Prostate-Specific Antigen Screening in a Medicare Advantage Population
Yingying Zhu, Benjamin Koethe, Daniel A Ollendorf, et al.
Pharmacoeconomics
|
September 24, 2021
Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic
Yumi Asukai, Andrew Briggs, Louis P Garrison, et al.
The International Journal of Cardiovascular Imaging
|
May 7, 2010
Cost-effective diagnostic cardiovascular imaging: when does it provide good value for the money?
Hansel J Otero, Frank J Rybicki, Dan Greenberg, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 29, 2025
Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation Study
Yingying Zhu, Natalia Olchanski, Karen M Freund, et al.
Page
of 31
Search research articles
Search
Showing results (201-210 of 301) with videos related to
Sort By:
Page
of 31
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 2, 2024
The Health Benefits, Costs, and Cost-Effectiveness of Ultraorphan Drugs
Katherine A Clifford, A Alex Levine, Daniel E Enright, et al.
JAMA
|
September 29, 2025
Variation in US Commercial Health Plan Coverage Restrictions for Cell and Gene Therapies
James D Chambers, Julia A Rucker, Daniel E Enright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2002
Impact of referral patterns on the use of chemotherapy for lung cancer
Craig C Earle, Peter J Neumann, Richard D Gelber, et al.
Journal of General Internal Medicine
|
April 16, 2020
Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan Drugs
James D Chambers, Madison C Silver, Flora C Berklein, et al.
Journal of Managed Care Pharmacy : JMCP
|
May 4, 2010
Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus
Joseph Menzin, Jonathan R Korn, Joseph Cohen, et al.
Health Economics
|
May 6, 2004
When does quality-adjusting life-years matter in cost-effectiveness analysis?
Richard H Chapman, Marc Berger, Milton C Weinstein, et al.
Medical Care
|
August 29, 2022
Effect of the 2012 US Preventive Services Task Force Recommendations on Prostate-Specific Antigen Screening in a Medicare Advantage Population
Yingying Zhu, Benjamin Koethe, Daniel A Ollendorf, et al.
Pharmacoeconomics
|
September 24, 2021
Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic
Yumi Asukai, Andrew Briggs, Louis P Garrison, et al.
The International Journal of Cardiovascular Imaging
|
May 7, 2010
Cost-effective diagnostic cardiovascular imaging: when does it provide good value for the money?
Hansel J Otero, Frank J Rybicki, Dan Greenberg, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 29, 2025
Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation Study
Yingying Zhu, Natalia Olchanski, Karen M Freund, et al.
Page
of 31